Proxy Votes Now

Home › Funds › Vanguard › Vanguard U.S. Multifactor ETF

Vanguard U.S. Multifactor ETF (VFMF) proxy voting record 2025-2026

Fund family: Vanguard · Filed by VANGUARD WELLINGTON FUND (CIK 105563) · SEC series S000061310

Ticker: VFMF (C000198481)

“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 6,085 with, 180 against, 0 abstentions (not counted as with management); 2 items carried no recommendation. Shareholder proposals: 9 FOR, 165 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Vanguard as a whole

The same two figures as Vanguard’s manager page (1,379,791 ballot items across 136 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsVanguardItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)98.9%5,95394.5%1,082,514
Backed environmental and social shareholder proposals at US companies0.0%820.9%6,718

Where this fund voted differently from most Vanguard funds

Each ballot item this fund voted is set against the votes of the other Vanguard funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted the same way as most Vanguard funds on all 6,200 items where a comparison was possible.

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 95.7% of this fund’s 6,265 such votes could be given a sector; the other 268 (4.3%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Consumer Discretionary1,530503.3%
Finance1,469322.2%
Health Care821212.6%
Technology755395.2%
Industrials618182.9%
Energy33430.9%
Consumer Staples188105.3%
Telecommunications12264.9%
Real Estate7000.0%
Miscellaneous4000.0%
Basic Materials2700.0%
Utilities2300.0%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections4,5146
Audit-related5820
Say-on-Pay5782
Compensation2285
Corporate Governance20281
Capital Structure590
Environment or Climate4040
Extraordinary Transactions370
Other Social Issues2827
Shareholder Rights and Defenses165

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
Micron Technology, Inc.January 15, 2026$32M121
AbbVie Inc.May 8, 2026$13M81
Altria Group, Inc.May 14, 2026$12M120
The Bank of New York Mellon CorporationApril 14, 2026$12M130
Merck & Co., Inc.May 26, 2026$11M183
Gilead Sciences, Inc.April 30, 2026$11M153
Newmont CorporationMay 12, 2026$11M140
HCA Healthcare, Inc.April 23, 2026$10M132

Notable votes against management

MeetingCompanyProposalFundMgmt
January 15, 2026Micron Technology, Inc.SHAREHOLDER PROPOSAL REQUESTING AMENDMENT TO SHAREHOLDER SPECIAL MEETING RIGHT. Shareholder proposalAgainstFor
May 8, 2026AbbVie Inc.Stockholder Proposal - to Adopt a Policy to Require an Independent Chair Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on DEI risks in federal contracting. Shareholder proposalAgainstFor
May 26, 2026Merck & Co., Inc.Shareholder proposal regarding a report on healthcare coverage gaps. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting an independent Board Chair policy, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 30, 2026Gilead Sciences, Inc.To vote on a stockholder proposal requesting a report on the impact of extended patent exclusivities on patient access, if properly presented at the Annual Meeting. Shareholder proposalAgainstFor
April 23, 2026HCA Healthcare, Inc.Stockholder proposal, if properly presented at the meeting, regarding a report on healthcare consequences. Shareholder proposalAgainstFor
April 23, 2026HCA Healthcare, Inc.Stockholder proposal, if properly presented at the meeting, regarding stockholders' right to act by written consent. Shareholder proposalAgainstFor
May 5, 2026Bristol-Myers Squibb CompanyShareholder Proposal on the Adoption of a Board Policy that the Chairperson of the Board be an Independent Director Shareholder proposalAgainstFor
May 19, 2026Amgen Inc.Stockholder proposal to require an independent board chairman. Shareholder proposalAgainstFor
May 14, 2026CVS Health CorporationStockholder Proposal for Reducing the Threshold for Our Stockholder Right to Act By Written Consent. Shareholder proposalAgainstFor
May 20, 2026The Travelers Companies, Inc.Shareholder proposal relating to a report on climate-related pricing and coverage decisions, if presented at the Annual Meeting of Shareholders. Shareholder proposalAgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (5 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

6,299 ballot items at 601 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, Vanguard U.S. Multifactor ETF (VFMF) voted at 601 shareholder meetings of 586 companies, on 6,299 ballot items in all. Where management made a recommendation, the fund followed it on 97.1% of the items and voted against it 180 times. Its most frequent area of disagreement was corporate governance (81 of its votes against management). It voted FOR 5.2% of the 174 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Vanguard's funds as a whole (98.9% against 94.5%). It voted the same way as most Vanguard funds on every item where a comparison was possible. 5 of its meetings were contested.

About this page

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Vanguard’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.